Florida Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Tech Today.

Press releases published on November 2, 2026

Nov. 2, 2026

UPDATE -- Leonardo DRS Selected by AV for U.S. Army’s Enduring-High Energy Laser Production Program

Indeterminate GlobeNewswire

Nov. 2, 2026

Opus Genetics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 2, 2026

Telos Board Appoints Executive Vice President Mark Griffin as CEO; John B. Wood to Serve as Executive Chairman

Indeterminate GlobeNewswire

Nov. 2, 2026

DBV Technologies to Participate in Upcoming November Investor Conferences

Indeterminate GlobeNewswire

Nov. 2, 2026

DBV Technologies participera aux prochaines Conférences Investisseurs en novembre

Indeterminate GlobeNewswire

Nov. 2, 2026

iBio to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 2, 2026

Recursion Reports Third Quarter 2026 Financial Results and Extends Cash Runway; Highlights Positive Clinical Data in REC-4881 and REC-1245, Sanofi Development Candidate Option and Appointment of Fred Hassan as Chair

Indeterminate GlobeNewswire

Nov. 2, 2026

Abivax to Participate in Upcoming Fall Investor Conferences

Indeterminate GlobeNewswire

Nov. 2, 2026

Abivax participera à plusieurs conférences investisseurs cet automne

Indeterminate GlobeNewswire

Nov. 2, 2026

Trevi Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 9, 2026

Indeterminate GlobeNewswire

Nov. 2, 2026

Regeneron Announces Investor Conference Presentations

Indeterminate GlobeNewswire

Nov. 2, 2026

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

Indeterminate GlobeNewswire

Nov. 2, 2026

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 2, 2026

Tactile Systems Technology, Inc. Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 2, 2026

Bioventus Reports Third Quarter Financial Results

Indeterminate GlobeNewswire

Nov. 2, 2026

EverQuote Announces Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 2, 2026

Relay Therapeutics to Participate in Three Upcoming Investor Conferences in November

Indeterminate GlobeNewswire

Nov. 2, 2026

Atea Pharmaceuticals to Host Third Quarter 2026 Financial Results and Business Update Conference Call on November 9, 2026

Indeterminate GlobeNewswire

Nov. 2, 2026

Spero Therapeutics to Present at Investor Conferences in November

Indeterminate GlobeNewswire

Nov. 2, 2026

Foresight Reminds Shareholders of Upcoming TASE Delisting and Encourages Conversion of Ordinary Shares into Nasdaq-Traded ADSs; BNY to Waive Issuance Fees Through January 7, 2027

Indeterminate GlobeNewswire